FDA approves Johnson & Johnson diabetes drug, canagliflozin

WASHINGTON | Fri Mar 29, 2013 3:13pm EDT

WASHINGTON (Reuters) – The U.S. Food and Drug Administration said on Friday it approved Johnson & Johnson’s experimental type 2 diabetes drug Invokana to help patients control their blood sugar.


Visit the Source Site